Clinical Trial

A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive Familial Intrahepatic Cholestasis (PFIC)-Related Genes to Symptoms in Adults With Recurrent Cholestasis in Spain

Study acronym: REGENIC
Completed
View on ClinicalTrials.gov →
Summary
Progressive Familial Intrahepatic Cholestasis (PFIC) is a group of inherited conditions that affect how bile moves in the liver, which can lead to serious liver problems. Doctors usually recommend genetic testing for patients with unexplained bile issues-after ruling out more common causes-to better understand the problem. However, there isn't much information on how common these genetic changes are in adults with these liver issues, especially in Spain. This study will observe these genetic changes so that doctors can diagnose the condition more clearly and create personalized treatment plans. This study will be conducted in several centers across Spain for 10 months. Each adult participant will take part in a single-day visit where their health information will be collected, and a blood sample will be taken for both routine tests and genetic analysis.
Protocol Amendment History 3 changes
critical Trial completed 2026-08-04
notable Primary completion moved earlier: 2026-07-31 -> 2026-06-03 2026-08-04
minor Completion moved earlier: 2026-07-31 -> 2026-06-03 2026-08-04
Trial Details
NCT Number NCT07191704
Lead Sponsor Ipsen
Conditions PFIC - Progressive Familial Intrahepatic Cholestasis
Enrollment 150 participants
Start Date 2025-12-08
Primary Completion 2026-06-03 (estimated)
Study Completion 2026-06-03 (estimated)
Updated on ClinicalTrials.gov 2026-08-03